Month: January 2023

Amsterdam, 18 January 2023: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announced that the U.S. Department of the Treasury, Office of Foreign Assets Control (OFAC) has replaced the General License 54 originally issued on 18 November 2022 with General License 54A to now include both VEON Ltd. and VEON Holdings B.V. (VEON Holdings). This general license authorizes all transactions ordinarily incident and necessary to the purchase and receipt of any debt or equity securities of VEON Ltd. or VEON Holdings that would otherwise be prohibited by section 1(a)(i) of Executive Order (E.O.) 14071. OFAC General License 54A applies to all debt and equity securities of VEON Ltd. or VEON Holdings that were issued before 6 June 2022, and confirms that the authorization...

Dr Nicco will oversee the development of pipeline across BioSenic’s cell therapy and autoimmune disease platform and will be responsible for R&D programs Mont-Saint-Guibert, Belgium, January 18, 2023, 7am CET – BioSenic(Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune /inflammatory diseases and cell repair, today announces it is strengthening its scientific team with the appointment of Dr. Carole Nicco, as Chief Scientific Officer (CSO). Dr Carole Nicco will be responsible for managing BioSenic’s scientific research and development. She will work closely with BioSenic’s CEO, Prof. François Rieger, to further supervise and enhance BioSenic’s strategic pipeline development, targeting treatments with its cell therapy and autoimmune disease platforms. “BioSenic is completing its C-level...

NoHo Partners Plc INVESTOR NEWS 18 JANUARY 2023 AT 08:00 EET NoHo Partners selected as the main supplier for restaurant services by Helsinki Expo and Convention Centre The restaurant company NoHo Partners has been selected as the main supplier for restaurant services by Helsinki Expo and Convention Centre (brand name Messukeskus) as of 1 July 2023. Helsinki Expo and Convention Centre is the largest venue for exhibitions, meetings and congresses in Finland, hosting national and international events for about a million visitors annually. The annual revenue from the restaurant services at the convention centre is approximately EUR 15 million. The cooperation with Helsinki Expo and Convention Centre is part of large urban projects that comprise one of the cornerstones of NoHo Partners’ profitable growth strategy, which aims EUR 400 million...

Deposits grew by 52% year on year Bigbank’s total deposit portfolio as at the end of 2022 amounted to 1,367.8 million euros, 52% up on a year earlier. At the end of 2021, deposits totalled 898.3 million euros. Savings deposits, which accounted for 621.8 million euros of total deposits at the year-end, grew by 82% compared with a year earlier (341.2 million euros at the end of 2021). Term deposits, which amounted to 746 million euros at the end of 2022, grew by 34% year on year (557.1 million euros at the end of 2021). Loan portfolio grew by 50% year on year The gross portfolio of loans issued by Bigbank stood at 1,356.8 million euros at the end of 2022, reflecting 50% growth on a year earlier (903.9 million euros at the end of 2021). Loans to individuals and corporate customers accounted for 66% and 34% of the total loan portfolio, respectively....

CAMBRIDGE, Mass., Jan. 17, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. ® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced the pricing of an underwritten public offering of 9,615,384 shares of its common stock at a public offering price of $13.00 per share. The gross proceeds to Fulcrum from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be $125 million. All shares in the offering are to be sold by Fulcrum Therapeutics. In addition, Fulcrum has granted the underwriters a 30-day option to purchase up to an additional 1,442,307 shares of its common stock. The offering is expected to close on or about January 20, 2023, subject to customary closing...